₹ 14820
₹540- ₹570
26
₹723
27
16 Jul 2025
Download18 Jul 2025
21 Jul 2025
Application Details
Anthem Biosciences IPO is a bookbuilding of ₹3,395.00 crores. The issue is entirely an offer for sale of 5.96 crore shares.
Anthem Biosciences IPO bidding opened for subscription on July 14, 2025 and will close on July 16, 2025. The allotment for the Anthem Biosciences IPO is expected to be finalized on Thursday, July 17, 2025. Anthem Biosciences IPO will be list on BSE, NSE with a tentative listing date fixed as Monday, July 21, 2025.
Anthem Biosciences IPO price band is set at ₹540 to ₹570 per share. The lot size for an application is 26. The minimum amount of investment required by an retail is ₹14,040 (26 shares). The lot size investment for sNII is 14 lots (364 shares), amounting to ₹2,07,480, and for bNII, it is 68 lots (1,768 shares), amounting to ₹10,07,760.
About Anthem Biosciences Limited
Company Overview
Incorporated in 2006, Anthem Biosciences Limited is an innovation-led and technology-focused Contract Research, Development, and Manufacturing Organization (CRDMO), offering fully integrated services that span drug discovery, development, and commercial manufacturing. The company is distinguished as the only Indian CRDMO with end-to-end capabilities in both small molecules and biologics, serving a global clientele that includes emerging biotech startups and top multinational pharmaceutical companies.
Core Capabilities and Operations
Anthem specializes in manufacturing fermentation-based APIs such as probiotics, enzymes, peptides, biosimilars, nutritional actives, and vitamin analogues. It is among the pioneers in India for green chemistry techniques, using advanced methods like biotransformation, micellar chemistry, flow chemistry, and pincer catalysis.
As of September 30, 2024, Anthem had:
- 196 active projects (including discovery, early and late development, and commercial manufacturing)
- Over 425 customers in the CRDMO and specialty ingredients segments across 44+ countries, including the U.S., Europe, and Japan
- A robust IP portfolio with eight granted patents (one in India, seven overseas) and 24 global patent applications pending
Additionally, the company has completed over 8,000 projects and has worked on molecules across 675+ clients during its 15+ years of operations.
FAQ
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.